Renaissance Technologies - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 49 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$781
-2.0%
125,791
+0.7%
0.00%0.0%
Q2 2023$797
+56.9%
124,891
-1.3%
0.00%0.0%
Q1 2023$508
-15.9%
126,491
-5.5%
0.00%0.0%
Q4 2022$604
-99.9%
133,891
-6.3%
0.00%
-50.0%
Q3 2022$1,072,000
-18.5%
142,949
-13.0%
0.00%0.0%
Q2 2022$1,315,000
-4.8%
164,346
-3.3%
0.00%0.0%
Q1 2022$1,382,000
-13.4%
169,939
-10.9%
0.00%0.0%
Q4 2021$1,595,000
-29.4%
190,746
-13.7%
0.00%
-33.3%
Q3 2021$2,258,000
-3.7%
221,146
-3.0%
0.00%0.0%
Q2 2021$2,344,000
-9.2%
228,046
-0.2%
0.00%0.0%
Q1 2021$2,581,000
+7.9%
228,433
+3.0%
0.00%0.0%
Q4 2020$2,393,000
+7.8%
221,746
-7.6%
0.00%
+50.0%
Q3 2020$2,220,000
+9.0%
240,026
+12.7%
0.00%0.0%
Q2 2020$2,036,000
+55.4%
212,946
+20.3%
0.00%
+100.0%
Q1 2020$1,310,000
-16.1%
177,046
-5.5%
0.00%0.0%
Q4 2019$1,561,000
+49.2%
187,346
+1.2%
0.00%0.0%
Q3 2019$1,046,000
-26.0%
185,046
+2.4%
0.00%0.0%
Q2 2019$1,414,000
-24.7%
180,646
-5.9%
0.00%
-50.0%
Q1 2019$1,879,000
+0.4%
191,946
-19.9%
0.00%0.0%
Q4 2018$1,871,000
-59.7%
239,546
-9.9%
0.00%
-60.0%
Q3 2018$4,644,000
+438.7%
265,846
+63.9%
0.01%
Q2 2018$862,000
+284.8%
162,200
+163.3%
0.00%
Q1 2018$224,000
-7.1%
61,600
-0.8%
0.00%
Q4 2017$241,000
+36.9%
62,095
+29.4%
0.00%
Q3 2017$176,000
+388.9%
48,000
+242.9%
0.00%
Q2 2017$36,00014,0000.00%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Battery Partners IX, LLC 1,953,549$10,451,0003.89%
NEA Management Company, LLC 1,562,500$8,359,0000.55%
Perceptive Advisors 745,194$3,986,0000.16%
Par Capital Management 833,333$4,458,0000.09%
SABBY MANAGEMENT, LLC 169,397$893,0000.04%
Alexandria Capital, LLC 1,188$6,0000.00%
MORGAN STANLEY 2,690$14,0000.00%
Tower Research Capital LLC (TRC) 47$00.00%
UBS Group AG 483$3,0000.00%
BANK OF AMERICA CORP /DE/ 2,089$11,0000.00%
View complete list of CHAMPIONS ONCOLOGY INC shareholders